raman gangakhedkar

Senior epidemiologist Dr raman gangakhedkar on Friday said there was no need for administering the fourth Covid booster dose among citizens unless a new variant of coronavirus was reported.“Currently, Omicron is widely in circulation in the community with new subvariants being reported.

The Union finance minister, Nirmala Sitharaman, on Saturday exhorted youth to be ready for change while staying rooted amid the transformation in the country.

Dr raman gangakhedkar, the former head scientist of epidemiology and communicable diseases at the Indian Council of Medical Research (ICMR), on Tuesday, appealed to the young doctors to practice their knowledge with compassion.

Dr Raman R Gangakhedkar, who had become the face of ICMR during government briefings to media on the coronavirus pandemic, retired as the head of epidemiology and communicable diseases at the apex health research body on Tuesday.

A total of 27,55,714 Covid-19 tests have been done so far in the country, said ICMR scientist Dr Raman R Gangakhedkar on Friday. Out of these one lakh tests, 85,542 tests were conducted at 401 government labs, and the rest were done at 178 private labs. Dr Gangakhedkar said that Friday was the fourth day when more than one lakh tests were done in one day.

A webinar on ‘Omicron and Beyond’ organized together by Academy of Medical Sciences (AMS) and Indian Medical Association, Nagpur (IMA) on Sunday proved like a booster dose in the fight against the Covid-19 pandemic as one of the highest authorities in public health in India expressed hope that together we can bid adieu of all types of coronaviruses soon.

India’s leading epidemiologist, Dr raman gangakhedkar, will be part of a 26-member expert team put together by World Health Organisation (WHO) to examine origins of pathogens such as SARS-CoV-2 that cause pandemics. Dr Gangakhedkar was former head of epidemiology at Indian Council of Medical Research (ICMR). A WHO statement on Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) described him as Dr C G Pandit National Chair at ICMR.

BF.7, the variant driving China's Covid surge, is not new and has been circulating in many countries for several months, without much impact. According to data released by the Scripps Research Institute, a total of 91 countries have had a variant matching the genetic make-up and mutation profile of BF.7 circulating since February 2021. It was finally named BF.7 (also BA.5.2.1.7) and added to the BA.5 Omicron lineage in May 2022, said an INSACOG scientist.

Covishield and Covaxin jabs can prevent hospitalisation and death that may come with the new Botswana variant Omicron (B.1.1.529), the nCoV’s most mutated version as yet, virologists and infectious diseases experts have said.

Monkeypox surveillance in India should be launched discreetly and carried out in a “faceless” manner to avoid directing stigma or blame at specific groups of people, experts have said. Anyone can get infected, but the current outbreak of the monkeypox virus—now a global health emergency—has been mainly among gay or bisexual men in the West. India has reported four cases so far, three with travel history.

President Ram Nath Kovind on Monday conferred the Padma awards on 119 people at Rashtrapati Bhawan in New Delhi. This year's list comprises seven Padma Vibhushan, 10 Padma Bhushan and 102 Padma Shri awards. Among the recipients, 29 are women, 16 posthumous awardees and one transgender awardee.

Covishield and Covaxin jabs can prevent hospitalisation or death that may result from the new Botswana variant Omicron (B.1.1.529), the Covid-19 virus’s most mutated version as yet, virologists and infectious diseases experts have said.

Widespread Covid vaccination is the best weapon against the possible third wave. So, advocating vaccination should be the goal of every physician, said Dr raman gangakhedkar, national chair of ICMR, while speaking in a webinar organized by Vidarbha Association of Medical Microbiologists (VAMM). The VAMM conducted te webinar in association with AIIMS Nagpur, on the topic ‘Mucormycosis: Diagnostic challenges, current guidelines and research priorities’.